Longitudinal Analysis of Raltegravir Susceptibility and Integrase Replication Capacity of Human Immunodeficiency Virus Type 1 during Virologic Failure

We characterized the raltegravir (RAL) susceptibility and the integrase (IN)-mediated replication capacity (RC) of RAL-resistant human immunodeficiency virus type 1 from two patients experiencing virologic failure during continuous RAL salvage therapy. The following two distinct outcomes were observ...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Fransen, Signe, Karmochkine, Marina, Huang, Wei, Weiss, Laurence, Petropoulos, Christos J., Charpentier, Charlotte
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology (ASM) 2009
Assuntos:
Antiviral Agents
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2764161/
https://ncbi.nlm.nih.gov/pubmed/19667293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00651-09
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares